MDNews - Central New York

March/April 2021

Issue link: https://viewer.e-digitaledition.com/i/1344691

Contents of this Issue

Navigation

Page 11 of 23

IT MAY BE possible to determine which localized prostate cancers will metas- tasize, even when caught very early on, according to a recent study published in Nature Cancer. " We identif ied a 16-gene signature that is enriched in bone meta sta sis, and that can predict whether localized tumors would metastasize early, as well as whether metastases are less likely to respond to current standard-of-care treat- ments," says lead author Juan Arriaga, PhD, a postdoctoral research scientist at Columbia University Vagelos College of Physicians and Surgeons and the school's Abate-Shen Lab. The research, while still in early stages, could have a significant impact on prostate cancer treatment. WHY IT MATTERS One in eight men will get prostate cancer in his lifetime, according to the American Ca ncer Societ y. For t unately, due to Can a Genetic Signature Predict Which Prostate Cancers Spread? BY CARI WADE GERVIN A NE W STUDY COULD LE AD TO BE T TER TAILORING OF TRE ATMENTS TO INDIVIDUAL PATIENTS. 1 2

Articles in this issue

Archives of this issue

view archives of MDNews - Central New York - March/April 2021